Wegovy® 0.5 mg is the second step in the once-weekly semaglutide titration schedule for chronic weight management in adults and adolescents with obesity or overweight-related health risks. Each single-use, prefilled pen delivers 0.5 mg of semaglutide in 0.5 mL and is used during weeks 5–8 of therapy. This stepwise dosing approach helps minimize gastrointestinal side effects and prepares patients to advance to higher, therapeutic maintenance doses.

Features:

• Step 2 Dose: Used after completing 4 weeks of 0.25 mg to continue safe titration.

• Once-Weekly Convenience: One injection per week supports long-term adherence.

• Prefilled, Ready-to-Use Pens: No mixing, dose setting, or visible needles.

• GLP-1 Receptor Agonist: Reduces hunger and calorie intake to promote weight loss.

• 4-Pack for 4 Weeks: One pen per week, designed for weeks 5 through 8 of therapy.